Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00017563 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
A Phase 2 study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
NCT00017563 is a Phase 2 study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 57 participants.
The verdict
NCT00017563, a Phase 2 study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy followed by surgery in treating patients who have localized prostate cancer.
Interventions
- DRUG docetaxel
- PROCEDURE conventional surgery
- DRUG mitoxantrone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2000-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00017563
The ClinicalTrials.gov registry entry for NCT00017563 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which docetaxel is the first listed.
NCT00017563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00017563 about?
NCT00017563 is a clinical study titled "Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase I/II trial to study the effective...
What is the current status of trial NCT00017563?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2000-09.
What interventions are being tested in trial NCT00017563?
The interventions under investigation include: docetaxel (DRUG), conventional surgery (PROCEDURE), mitoxantrone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00017563?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.